PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
60 hedge funds and large institutions have $168M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
60
Holders Change
+20
Holders Change %
+50%
% of All Funds
1.04%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
27
Increased
14
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$6.15M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$6.58M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$2.11M |
4 |
4
State Street
Boston,
Massachusetts
|
$1.88M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$1.07M |